Vimarsana
Biggest News Aggregation in the World

Page 3 - Creation House News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Creation House. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Creation House Today - Breaking & Trending Today

Adcendo presents Data on uPARAP targeting ADCs in Osteosarcoma PDX Models at the 2022 AACR Annual Meeting - Vimarsana News

Adcendo presents Data on uPARAP targeting ADCs in Osteosarcoma PDX Models at the 2022 AACR Annual Meeting

/PRNewswire/ -- Adcendo ApS ("Adcendo"), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of...

Human Strategy Series: Interview with Dr Jackie Ameri, CEO of Pancryos - Vimarsana News

Human Strategy Series: Interview with Dr Jackie Ameri, CEO of Pancryos

“I like the excitement of not knowing what’s going to happen and I think I thrive on it.”For the first interview in our Human Strategy Series,  the team recently spoke with Dr Jackie Ameri, CEO of Pancryos, who benefited from our Leadership Assessment service as part of the partnership between...

Technical University of Denmark: Prospect for home tests for patients with low metabolism - Vimarsana News

Technical University of Denmark: Prospect for home tests for patients with low metabolism

Home monitoring of the body's production of metabolic hormone may become a reality for more than 200 million patients living with low metabolism. A new digital start-up company from DTU, HEI Therapeutics, is developing the world's first home monitori

Adcendo Raises EUR 51M in Series A Financing - Vimarsana News

Adcendo Raises EUR 51M in Series A Financing

Adcendo, a Copenhagen, Denmark-based biotech company which is developing antibody-drug conjugates (ADCs) for the treatment of cancers, raised EUR 51m (US$ 62m) in Series A financing. The round was led by Novo Seeds and Ysios Capital, with participation from RA Capital Management, HealthCap and Gilde Healthcare. As part of the financing, Jeroen Bakker, Principal at Novo Seeds, will join the Board. The company plans to use the funds to bring the lead program targeting the novel cancer target uPARAP/Endo180 to proof of concept in patients. Founded in 2017 by scientists Niels Behrendt, Lars Henni...

BioInnovation Institute takes in new cohort of promising early-stage innovations - Vimarsana News

BioInnovation Institute takes in new cohort of promising early-stage innovations

Share this article Share this article Seven start-up companies and university research projects across a range of therapeutic areas and geographical locations form latest intake for life science incubator BioInnovation Institute COPENHAGEN, Denmark, Dec. 2, 2020 /PRNewswire/ -- BioInnovation Institute (BII), a Novo Nordisk Foundation initiative incubating and accelerating world-class life science research, today identifies its latest cohort of program participants. Comprising a pan-European spread of start-up companies and university research projects in countries including Denmark, Sweden a...